Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

UnitedHealth Group Incorporated (UNH) SEC Filings & Earnings Calls

EquiReason read 18 UnitedHealth Group Incorporated SEC filings in the last 12 months. Latest: 8-K on 2026-10-13 — UNH reported Q3 2026 revenues of $112.7B, EPS $4.56, adjusted EPS $4.69, raised FY2026 guidance to at least $19.50/$20.50 per share. Medical cost ratio 88.4%, operating cost ratio .

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

UNHUnitedHealth Group IncorporatedFollow UNH — free
Healthcare Plans · Healthcare
—
Price chart with a free account
Market cap
375.3B
P/E TTM
26.9
Dividend yield
2.1%
52-week
—
Next earnings
25 Jan, in 93 days

Every filing, read

last 12 months · SEC

What happened, the numbers inside, guidance and risks. The original is one click away.

13 Oct 20268-K · 2.02UNH reported Q3 2026 revenues of $112.7B, EPS $4.56, adjusted EPS $4.69, raised FY2026 guidance to at least $19.50/$20.50 per share. Medical cost ratio 88.4%, operating cost ratio improved to 12.8% from 13.5% YoY. Cash flow from operationsearningsopen

Figures in the filing · each found in the filing text

Revenue · Q3-2026$112.70B
Earnings from Operations · Q3-2026$6.60B
Net Earnings per Share (GAAP) · Q3-2026$4.56
Adjusted Net Earnings per Share · Q3-2026$4.69
Cash Flows from Operations · Q3-2026$5.10B
Medical Cost Ratio · Q3-202688.4%
Operating Cost Ratio · Q3-202612.8%
Debt-to-Capital Ratio · 2026-09-3041.7%
UnitedHealthcare Revenue · UnitedHealthcare · Q3-2026$86.30B
UnitedHealthcare Earnings · UnitedHealthcare · Q3-2026$2.80B

Guidance

FY2026 GAAP EPS at least $19.50; adjusted EPS at least $20.50

Raised full-year 2026 adjusted EPS guidance to at least $20.50 from prior, reflecting strong Q3 performance and confidence in continued execution

Risks flagged

Medical cost ratio of 88.4% reflects ongoing medical cost management, but prior period reserve development of $610M favorable may not recur

“MCR was impacted by $610 million of net favorable prior period reserve development related to 2026 dates of service” · word for word
Read the original on SEC EDGAR ↗
8 Sep 20268-K · 7.01UnitedHealth Group senior leaders will present at Wells Fargo Healthcare Conference; no financial results or guidance disclosed.SEC ↗
10 Aug 202610-QUnitedHealth Group reported strong Q2 2026 results with earnings from operations up 55% YoY, driven by lower medical costs and favorable reserve development.earningsopen

Figures in the filing · each found in the filing text

Revenue · Q2-2026$112.03B+0% y/y
Net Earnings Attributable to UNH · Q2-2026$5.48B+61% y/y
Earnings from Operations · Q2-2026$7.99B+55% y/y
Operating Cash Flow · H1-2026$19.96B+58% y/y
Diluted EPS · Q2-2026$6.04+62% y/y
UnitedHealthcare Earnings from Operations · UnitedHealthcare · Q2-2026$3.94B+90% y/y
Optum Health Earnings from Operations · Optum Health · Q2-2026$1.19B+177% y/y
Optum Insight Earnings from Operations · Optum Insight · Q2-2026$1.37B+14% y/y
Optum Rx Earnings from Operations · Optum Rx · Q2-2026$1.49B+3% y/y
Cash and Cash Equivalents · 2026-06-30$28.59B

Risks flagged

IRS Transfer Pricing Dispute

“On March 6, 2026, the Company received Notices of Proposed Adjustment ("NOPAs") from the IRS for transactions undertaken during the 2017 through 2020 tax years involving intercompany transfer pricing with a foreign subsidiary. The IRS is seeking to significantly increase taxable income for each of the applicable periods” · word for word

DOJ Risk Adjustment Lawsuit

“In March 2025, a Special Master appointed by the court issued a report recommending that the court enter summary judgment in the Company’s favor on all remaining claims. In April 2025, the DOJ filed a motion asking the court to reject the Special Master’s report.” · word for word

South American Operations Exit Losses

“Losses related to this transaction are included within loss on sale of subsidiary and subsidiaries held for sale on the Condensed Consolidated Statements of Operations as they relate to the strategic exit of South American markets and include significant losses related to foreign currency translation effects.” · word for word
Read the original on SEC EDGAR ↗
16 Jul 20268-K · 2.02UNH reported Q2 2026 revenues of $112.0B, EPS $6.04, adjusted EPS $6.38; raised FY2026 adjusted EPS guidance to $19.50-$20.00 from prior range; MCR 86.7%; operating cash flow $11.1B; strong performance across segments.earningsopen

Figures in the filing · each found in the filing text

Revenue · Q2-2026$112.00B
Earnings per share (diluted) · Q2-2026$6.04
Adjusted earnings per share (diluted) · Q2-2026$6.38
Medical care ratio · Q2-202686.7%
Operating cost ratio · Q2-202612.7%
Cash flows from operations · Q2-2026$11.10B
Debt-to-capital ratio · Q2-202641.2%
UnitedHealthcare revenue · UnitedHealthcare · Q2-2026$86.00B
UnitedHealthcare earnings · UnitedHealthcare · Q2-2026$3.90B
UnitedHealthcare operating margin · UnitedHealthcare · Q2-20264.6%

Guidance

FY2026 adjusted net earnings per share raised to $19.50-$20.00 from prior range; FY2026 reported EPS $18.45-$18.95; FY2026 medical care ratio 88.1% ± 25 bps; FY2026 tax rate ~18.5%; FY2026 cash flows from operations ~$24B; FY2026 share repurchase at least $5B; FY2026 net earnings to UNH shareholders >$16.75B; FY2026 UnitedHealthcare operating earnings >$12B; FY2026 Optum Health operating earnings

Raised full year 2026 adjusted EPS guidance reflecting strong performance and improved outlook

Risks flagged

Operating cost ratio increased from 12.3% to 12.7% due to investments; potential margin pressure if investments do not yield returns

“Operating cost ratio of 12.7% in the second quarter 2026 compared to 12.3% in the second quarter 2025, reflecting targeted investments” · word for word

Medical cost ratio includes favorable prior period development; underlying trend may be higher

“MCR was affected by $860 million of net favorable prior period development, with the majority related to 2026 dates of service” · word for word
Read the original on SEC EDGAR ↗
11 May 20268-K · 7.01UnitedHealth Group announces participation in a healthcare conference with an interview format; no material financial or operational update in the 8-K body.SEC ↗
5 May 202610-QTotal revenues $111.72B (+2% y/y); Net earnings attributable to UnitedHealth Group common shareholders $6.28B (-0% y/y); Diluted earnings per share $6.90 (+1% y/y)open

Figures in the filing · each found in the filing text

Total revenues · Q1-2026$111.72B+2% y/y
Net earnings attributable to UnitedHealth Group common shareholders · Q1-2026$6.28B-0% y/y
Diluted earnings per share · Q1-2026$6.90+1% y/y
Medical care ratio · Q1-202683.9%
Operating margin · Q1-20268.0%
Cash flows from operating activities · Q1-2026$8.91B+63% y/y
Cash and cash equivalents · 2026-03-31$28.00B
UnitedHealthcare earnings from operations · UnitedHealthcare · Q1-2026$5.69B+9% y/y
Optum Health earnings from operations · Optum Health · Q1-2026$1.14B-19% y/y
Optum Insight earnings from operations · Optum Insight · Q1-2026$963M-17% y/y

Risks flagged

Medicare Advantage funding pressure

“Medicare Advantage funding continues to be pressured... Continued funding pressures have resulted in benefit and pricing actions, causing contraction in our Medicare Advantage membership in the first quarter, which we expect to continue throughout 2026.” · word for word

Medicaid rate inadequacy

“Due to elevated care activity in Medicaid... there continues to be a timing mismatch between the health status of people served and state rate updates.” · word for word

Medical cost trend pressure

“As expected and contemplated in our benefits design and pricing, we have continued to observe increased care patterns; health care unit costs; and the intensity of services delivered.” · word for word

IRS transfer pricing dispute

“On March 6, 2026, we received Notices of Proposed Adjustment (“NOPAs”) from the IRS for transactions undertaken during the 2017 through 2020 tax years involving intercompany transfer pricing with a foreign subsidiary. The IRS is seeking to significantly increase taxable income for each of the applicable periods.” · word for word
Read the original on SEC EDGAR ↗
21 Apr 20268-K · 2.02Revenue $111.70B (+2% y/y); Adjusted net earnings per share $7.23; Medical cost ratio 83.9; Guidance: Raised full year 2026 adjusted EPS guidance to >$18.25 from >$17.35earningsopen

Figures in the filing · each found in the filing text

Revenue · Q1-2026$111.70B+2% y/y
Adjusted net earnings per share · Q1-2026$7.23
Medical cost ratio · Q1-202683.9%
Operating cost ratio · Q1-202613.8%
Cash flows from operations · Q1-2026$8.90B
Debt-to-capital ratio · Q1-202642.9%
UnitedHealthcare consumers served · UnitedHealthcare · Q1-202649,100,000
Optum revenues · Optum · Q1-2026$63.70B
Optum earnings · Optum · Q1-2026$3.30B
Full year 2026 adjusted EPS guidance · FY2026$18.25

Guidance

Raised full year 2026 adjusted EPS guidance to >$18.25 from >$17.35

Raised full-year adjusted EPS guidance to >$18.25, reflecting strong Q1 performance and operational improvements.

Risks flagged

Elevated utilization and unit cost trends persist

“consistently elevated utilization and unit cost trends” · word for word

Operating cost ratio increased due to investments

“operating cost ratio of 13.8% in the first quarter 2026 compared to 12.4% in the first quarter 2025” · word for word
Read the original on SEC EDGAR ↗
21 Apr 2026DEF 14AProxy statement detailing executive compensation, governance, and shareholder proposals, including a response to a 60% Say-on-Pay vote and disclosure of significant underperformance in incentive metrics.open

Figures in the filing · each found in the filing text

Revenue · FY2025$461.70B
Operating Income · FY2025$38.50B
Cash Flow from Operations · FY2025$32.00B
Net Income · FY2025$12.81B
Adjusted EPS · FY2025$16.35
Cumulative Adjusted EPS (3-year) · 2023-2025$71.40
Return on Equity (3-year average) · 2023-202523.1%
TSR (5-year cumulative) · 2021-2025$102.00
CEO Pay Ratio · FY2025$748.00
Median Employee Compensation · FY2025$81474.00

Risks flagged

Executive Compensation Misalignment

“At the 2025 Annual Meeting, our Say-on-Pay proposal received 60% support.” · word for word

Financial Underperformance

“2025: Net Income ($) 12,807,000,000; Adjusted EPS ($) 16.35; 2024: Net Income ($) 15,242,000,000; Adjusted EPS ($) 27.66”

Governance Risk - Combined CEO/Chair

“given the extraordinary circumstances the Company faced last year, our Board determined that we and our shareholders were best served by appointing Stephen Hemsley as CEO and Chair” · word for word

Shareholder Dissatisfaction

“At the 2025 Annual Meeting, our Say-on-Pay proposal received 60% support.” · word for word
Read the original on SEC EDGAR ↗
9 Mar 20268-K · 7.01UNH files 8-K for participation in Barclays conference; no material financial or operational update disclosed.SEC ↗
2 Mar 20268-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)SEC ↗
2 Mar 202610-KOptum Insight backlog $31.10B (-5% y/y); Pharmaceutical spending managed $188.00B; Specialty pharmaceutical spending managed $87.00Bopen

Figures in the filing · each found in the filing text

Optum Insight backlog · Optum Insight · 2025-12-31$31.10B-5% y/y
Pharmaceutical spending managed · Optum Rx · FY2025$188.00B
Specialty pharmaceutical spending managed · Optum Rx · FY2025$87.00B
Employer & Individual membership · UnitedHealthcare Employer & Individual · 2025-12-3129,700,000
Medicare Advantage membership · UnitedHealthcare Medicare & Retirement · 2025-12-318,400,000
Medicare Part D membership · UnitedHealthcare Medicare & Retirement · 2025-12-3110,400,000
Medicare Supplement membership · UnitedHealthcare Medicare & Retirement · 2025-12-314,300,000
Community & State membership · UnitedHealthcare Community & State · 2025-12-317,400,000
Optum Financial consumer accounts · Optum Financial · 2025-12-3126,000,000
Optum Financial assets under management · Optum Financial · 2025-12-31$27.00B

Risks flagged

Medical cost estimation risk

“If we fail to estimate, price for and manage our medical costs or design benefits in an effective manner, the profitability of our risk-based products and services could decline.” · word for word

Cyberattack risk

“We previously reported that our Change Healthcare business ... was subject to a cyberattack in 2024, in which the data involved contained protected health information or personally identifiable information.” · word for word

Regulatory risk

“Our business activities in the United States and other countries are highly regulated and new laws or regulations or changes in existing laws or regulations or their enforcement or application could materially and adversely affect our business.” · word for word

Goodwill impairment risk

“As of December 31, 2025, our goodwill and other intangible assets had a carrying value of $131 billion, representing 42% of our total consolidated assets.” · word for word
Read the original on SEC EDGAR ↗
25 Feb 20268-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)open

Risks flagged

No material risk; minor governance change.

Read the original on SEC EDGAR ↗
27 Jan 20268-K · 2.02Revenue $447.60B (+12% y/y); Adjusted Earnings Per Share $16.35; Net Earnings Per Share $13.23; Guidance: FY2026 revenue >$439B, adj. EPS >$17.75, ops earnings >$24Bearningsopen

Figures in the filing · each found in the filing text

Revenue · FY2025$447.60B+12% y/y
Adjusted Earnings Per Share · FY2025$16.35
Net Earnings Per Share · FY2025$13.23
Earnings from Operations · FY2025$19.00B
Cash Flows from Operations · FY2025$19.70B
Adjusted Medical Care Ratio · FY202588.9%
Operating Cost Ratio · FY202513.3%
UnitedHealthcare Revenue · UnitedHealthcare · FY2025$344.90B+16% y/y
Optum Revenue · Optum · FY2025$270.60B+7% y/y
UnitedHealthcare Members Served · UnitedHealthcare · FY202549,800,000

Guidance

FY2026 revenue >$439B, adj. EPS >$17.75, ops earnings >$24B

FY2026 guidance implies revenue slightly below FY2025 but earnings growth (adj. EPS $17.75 vs $16.35) driven by operational improvements and cost discipline, despite medical cost headwinds.

Risks flagged

Medical cost ratio increased 340bps YoY due to CMS Medicare funding cuts, IRA changes, and medical cost trends

“The full year 2025 adjusted medical care ratio was 88.9% compared to 85.5% in 2024. The year-over-year increase reflects previously disclosed factors, CMS’s Medicare funding reductions and changes from the Inflation Reduction Act combined with accelerating medical cost trends.” · word for word

One-time $1.6B charge for cyberattack, divestitures, and restructuring indicates operational disruption

“The company completed wide-ranging actions that were included in a fourth quarter charge of $1.6 billion net of taxes, or $1.78 per share. The impacts were largely non-cash and were excluded from adjusted earnings.” · word for word

Days claims payable declined sequentially and YoY, partly due to IRA Part D impact, which may pressure working capital

“Days claims payable were 44.1 compared to 46.2 in third quarter 2025 and 47.0 at year end 2024. The decline reflected expected impacts from the Inflation Reduction Act on the Part D program of approximately four days year-over-year.” · word for word
Read the original on SEC EDGAR ↗
12 Jan 20268-K · 7.01UnitedHealth Group reaffirms adjusted 2025 EPS expectations previously disclosed on Oct 28, 2025; no new numbers or changes provided.open

Guidance

Adjusted 2025 EPS expectations reaffirmed; no specific numbers provided.

Reaffirmation of prior adjusted EPS guidance for FY2025; no new quantitative details.

Risks flagged

Financial closing procedures not yet complete; actual results may change.

“Our financial closing procedures for the full-year 2025 are not yet complete and, as a result, our actual results may change” · word for word
Read the original on SEC EDGAR ↗
21 Nov 20258-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)SEC ↗
7 Nov 20258-K · 7.01Regulation FD disclosure announcing participation in UBS Global Healthcare Conference 2025; no material financial or operational update.SEC ↗
28 Oct 20258-K · 2.02Revenue $113.20B (+12% y/y); Earnings from operations $4.30B (-50% y/y); Net margin 2.1; Guidance: FY2025 adjusted EPS at least $16.25earningsopen

Figures in the filing · each found in the filing text

Revenue · Q3-2025$113.20B+12% y/y
Earnings from operations · Q3-2025$4.30B-50% y/y
Net margin · Q3-20252.1%
Medical care ratio · Q3-202589.9%
Adjusted EPS · Q3-2025$2.92
GAAP EPS · Q3-2025$2.59
Cash flows from operations · Q3-2025$5.90B
UnitedHealthcare revenue · UnitedHealthcare · Q3-2025$87.10B+16% y/y
Optum revenue · Optum · Q3-2025$69.20B+8% y/y
Domestic consumers served · UnitedHealthcare · Q3-202550,100,000+2% y/y

Guidance

FY2025 adjusted EPS at least $16.25

Raised FY2025 adjusted EPS guidance to at least $16.25, reflecting confidence in revenue growth despite margin pressure.

Risks flagged

Elevated medical cost trend and Medicare funding reductions pressuring margins significantly.

“Medical care ratio 89.9% vs 85.2% YoY; operating margin 2.1% vs 6.0% YoY; effects of Biden-era Medicare funding reductions and Part D IRA impacts.”

Optum Health margin collapse from 8.3% to 1% due to reimbursement pressure and elevated utilization.

“Optum Health operating margin 1% vs 8.3% YoY; driven by continued reimbursement pressure due to Medicare funding reductions and elevated utilization and costs.”
Read the original on SEC EDGAR ↗
28 Oct 202510-QUnitedHealth Group reported a sharp earnings decline in Q3 2025, with earnings from operations falling 50% YoY, driven by medical cost trends significantly exceeding pricing assumptions.open

Figures in the filing · each found in the filing text

Total revenues · Q3-2025$113.16B+12% y/y
Net earnings attributable to UnitedHealth Group common shareholders · Q3-2025$2.35B-61% y/y
Earnings from operations · Q3-2025$4.32B-50% y/y
Medical costs · Q3-2025$79.96B+21% y/y
Optum Health earnings from operations · Optum Health · Q3-2025$255M-88% y/y
UnitedHealthcare earnings from operations · UnitedHealthcare · Q3-2025$1.80B-57% y/y
Operating cash flow · 9M-2025$18.59B-15% y/y

Risks flagged

Medical cost trend exceeds pricing assumptions

“For 2025, our pricing trends and patient and member health status assumptions were well-short of the medical cost trends incurred, significantly impacting our earnings.” · word for word

Medicare Advantage funding pressure

“Medicare Advantage funding continues to be pressured, as discussed below in 'Regulatory Trends and Uncertainties,' and we have observed increased care patterns as discussed below in 'Medical Cost Trends,' which may impact pricing and benefit design in future periods.” · word for word

Medicaid rate mismatch

“The Medicaid redetermination process has caused a timing mismatch between the health status of people served through Medicaid and state rate updates.” · word for word

DOJ risk adjustment litigation

“In March 2025, a Special Master appointed by the court issued a report recommending that the court enter summary judgment in the Company's favor on all remaining claims. In April 2025, the DOJ filed a motion asking the court to reject the Special Master's report.” · word for word
Read the original on SEC EDGAR ↗

UnitedHealth Group Incorporated — questions

What did UnitedHealth Group Incorporated file recently?
18 SEC filings in the last 12 months. Latest: 8-K on 2026-10-13 — UNH reported Q3 2026 revenues of $112.7B, EPS $4.56, adjusted EPS $4.69, raised FY2026 guidance to at least $19.50/$20.50 per share. Medical cost ratio 88.4%, operating cost ratio improved to 12.8% from 13.5% YoY. Cash flow from operations

Every figure on this page comes from UnitedHealth Group Incorporated's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.